Related Experiment Videos
Decrease of macrovascular hyperemic response of blood flow in diabetics with arterial neuropathy.
K H Vogelberg1, P Mayer, M König
1Klinische Abteilung des Diabetes-Forschungs-Instituts, Universität Düsseldorf.
Summary
Diabetic patients show reduced pedal blood flow, especially with longer disease duration and neuropathy. This impaired vascular response in diabetic feet may contribute to gangrene development.
Area of Science:
- Vascular Medicine
- Diabetology
- Neurology
Background:
- Diabetes mellitus is associated with microvascular and macrovascular complications.
- Peripheral neuropathy is a common complication, affecting both nerve function and blood flow.
- Diabetic foot complications, including gangrene, are a significant concern.
Purpose of the Study:
- To investigate the macrovascular hyperemic response of pedal blood flow in diabetic subjects.
- To assess the correlation between blood flow, diabetes duration, and peripheral neuropathy.
- To determine if reduced blood flow occurs early in diabetic neuropathy.
Main Methods:
- Doppler sonography was used to examine pedal blood flow in 51 diabetic subjects and 20 non-diabetic controls.
- Vascular response was measured and correlated with diabetes duration and presence of somatic and autonomic neuropathy.
- Nerve conduction time and arterial pulsation were assessed.
Main Results:
- Pedal blood flow hyperemic response was negatively correlated with diabetes duration (p<0.01).
- Newly diagnosed diabetics showed increased response (+210%), while long-term diabetics showed decreased response (-20%).
- Reduced blood flow correlated with peripheral neuropathy (p<0.001), including somatic (142±152%) and autonomic (152±88%) types, compared to controls (293±108%).
Conclusions:
- Macrovascular hyperemic response is reduced in diabetic feet, even early in peripheral neuropathy.
- This functional reduction in pedal blood flow may be a precursor to diabetic foot gangrene.
- Findings highlight the importance of assessing vascular function in diabetic neuropathy management.